BPC-157
Pentadecapeptide, gastric-juice derived sequence
- CAS
- 137525-51-0
- Formula
- C62H98N16O22
- MW
- 1419.5
- Strength
- 5 mg · 10 mg
- Unit
- 1 vial
- Purity
- See report
This website is for sale. Find out more here.
Shop
Lyophilised powder in sealed glass vials, sold by the vial. Chemical identity on every listing, and a link to the certificate for the batch in stock.
Pentadecapeptide, gastric-juice derived sequence
Acetylated fragment, Ac-LKKTETQ-OH
BPC-157 and TB-500, 1:1 blended unit
Copper(II) complex of glycyl-histidyl-lysine
GHK-Cu, TB-500 and BPC-157, blended unit
Twenty-nine-residue peptide, without DAC
Pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2
Sixteen-residue mitochondrial-derived peptide
Tetrapeptide, Ala-Glu-Asp-Gly
Tetrapeptide, D-Arg-Dmt-Lys-Phe-NH2
Nicotinamide adenine dinucleotide, oxidised form
Triple receptor agonist peptide
Heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro
Twenty-eight-residue acetylated peptide
Hexanoic-acid-capped peptide derivative, pellets
Phenyltropane small molecule, pellets
BPC-157 pentadecapeptide, pellets
Quinolinium small molecule, pellets
Laboratory supply, sealed glass vial
All products are supplied for in-vitro laboratory research only. They are not medicines, not for human or veterinary use, not for food use, and are not offered for the diagnosis, treatment, cure or prevention of any condition. No protocol, quantity or method of administration is supplied with any product. Determining suitability for a given experiment is the researcher’s responsibility. By purchasing you confirm you are a qualified researcher.